litlas
Log inCreate account

J.S. Elborn

Active 1990–2025

146
Papers
26,307
Citations
84
h-index
143
i10-index

Citations

Citations per year for J.S. Elborn1970: 1 citations1978: 2 citations1990: 3 citations1991: 1 citations1992: 3 citations1993: 9 citations1994: 5 citations1995: 13 citations1996: 12 citations1997: 17 citations1998: 20 citations1999: 17 citations2000: 31 citations2001: 18 citations2002: 21 citations2003: 26 citations2004: 25 citations2005: 17 citations2006: 23 citations2007: 27 citations2008: 45 citations2009: 69 citations2010: 80 citations2011: 77 citations2012: 102 citations2013: 160 citations2014: 196 citations2015: 173 citations2016: 259 citations2017: 232 citations2018: 295 citations2019: 1,028 citations2020: 1,151 citations2021: 1,151 citations2022: 850 citations2023: 613 citations2024: 1,051 citations2025: 413 citations2026: 4 citations1971–1977: no citations, so these years are not shown1979–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,973 citing papers, 21.7% of this breakdownUnited Kingdom: 1,132 citing papers, 12.4% of this breakdownItaly: 552 citing papers, 6.1% of this breakdownGermany: 540 citing papers, 5.9% of this breakdownAustralia: 453 citing papers, 5% of this breakdownCanada: 436 citing papers, 4.8% of this breakdownChina: 434 citing papers, 4.8% of this breakdownFrance: 419 citing papers, 4.6% of this breakdownSpain: 322 citing papers, 3.5% of this breakdownNetherlands: 313 citing papers, 3.4% of this breakdownBelgium: 212 citing papers, 2.3% of this breakdownIreland: 212 citing papers, 2.3% of this breakdown
0%21.7%Other 23.2%

Institutions

Fields

  • Medicine73%
  • Biochemistry, Genetics and Molecular Biology15.9%
  • Immunology and Microbiology5.2%
  • Environmental Science1%
  • Health Professions0.7%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Other3.6%

Topics

  • Cystic Fibrosis Research Advances18%
  • Neonatal Respiratory Health Research7%
  • Chronic Obstructive Pulmonary Disease (COPD) Research3.7%
  • Tracheal and airway disorders3.4%
  • Gut microbiota and health2.7%
  • Asthma and respiratory diseases2.6%
  • Other62.6%

Coauthors

All papers

Open in search
  1. European Respiratory Society guidelines for the management of adult bronchiectasis

    Authors: Eva Polverino, Pieter Goeminne, Melissa J. McDonnell, Stefano Aliberti, Sara E. Marshall, Michael R. Loebinger, Marlène Murris, Rafael Cantón, Antoni Torres, Katerina Dimakou, Anthony De Soyza, Adam T. Hill, Charles Haworth, Montserrat Vendrell, Felix C. Ringshausen, Dragan Subotic, Robert Wilson, Jordi Vilaró, Björn Ställberg, Tobias Welte, Gernot Rohde, Francesco Blasi, J.S. Elborn, Marta Almagro, Alan Timothy, Thomas Ruddy, Thomy Tonia, David Rigau, James D. Chalmers - European Respiratory Journal 2017 cited by 1,344

  2. Cystic fibrosis

    Authors: J.S. Elborn - The Lancet 2016 cited by 1,677

  3. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC)

    Authors: James D. Chalmers, Eva Polverino, Megan Crichton, Felix C. Ringshausen, Anthony De Soyza, Montserrat Vendrell, Pierre‐Régis Burgel, Charles Haworth, Michael R. Loebinger, Katerina Dimakou, Marlène Murris, Robert C. Wilson, Adam T. Hill, Rosario Menéndez, Antoní Torres, Tobias Welte, Francesco Blasi, Josje Altenburg, Michal Shteinberg, Wim Boersma, J.S. Elborn, Pieter Goeminne, Stefano Aliberti - The Lancet Respiratory Medicine 2023 cited by 280

  4. A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation

    Authors: Bonnie W. Ramsey, Jane C. Davies, Noel G. McElvaney, Elizabeth Tullis, Scott C. Bell, Pavel Dřevínek, Matthias Griese, Edward F. McKone, Claire Wainwright, Michael W. Konstan, Richard B. Moss, Félix Ratjen, Isabelle Sermet‐Gaudelus, Steven M. Rowe, Qunming Dong, Sally Rodriguez, Karl Yen, Claudia L. Ordoñez, J.S. Elborn - New England Journal of Medicine 2011 cited by 2,174

  5. Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR

    Authors: Claire Wainwright, J.S. Elborn, Bonnie W. Ramsey, Gautham Marigowda, Xiaohong Huang, Marco Cipolli, Carla Colombo, Jane C. Davies, K. De Boeck, Patrick A. Flume, Michael W. Konstan, Susanna A. McColley, Karen McCoy, Edward F. McKone, À. Munck, Félix Ratjen, Steven M. Rowe, David Waltz, Michael Boyle - New England Journal of Medicine 2015 cited by 1,621

  6. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations

    Authors: Stefano Aliberti, Pieter Goeminne, Anne E. O’Donnell, Timothy R. Aksamit, Hamdan Al‐Jahdali, Alan F. Barker, Francesco Blasi, Wim Boersma, Megan Crichton, Anthony De Soyza, Katerina Dimakou, J.S. Elborn, Charles Feldman, Harm Tiddens, Charles Haworth, Adam T. Hill, Michael R. Loebinger, Miguel Ángel Martínez‐García, Jennifer J. Meerburg, Rosario Menéndez, Lucy Morgan, Marlène Murris, Eva Polverino, Felix C. Ringshausen, Michal Shteinberg, Nicola Sverzellati, Gregory Tino, Antoní Torres, Thomas Vandendriessche, Montserrat Vendrell, Tobias Welte, Robert C. Wilson, Conroy Wong, James D. Chalmers - The Lancet Respiratory Medicine 2021 cited by 285

  7. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study

    Authors: Holly R. Keir, Amelia Shoemark, Alison Dicker, Lídia Perea, Jennifer S. Pollock, Yan Hui Giam, Guillermo Suárez-Cuartín, Megan Crichton, Mike Lonergan, Martina Oriano, Erin Cant, G.G. Einarsson, Elizabeth Furrie, J.S. Elborn, Christopher J. Fong, Simon Finch, Geraint B. Rogers, Francesco Blasi, Oriol Sibila, Stefano Aliberti, Jodie L. Simpson, Jeffrey Huang, James D. Chalmers - The Lancet Respiratory Medicine 2021 cited by 238

  8. Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

    Authors: Jennifer L. Taylor‐Cousar, À. Munck, Edward F. McKone, Cornelis K. van der Ent, Alexander Moeller, C Simard, Linda T. Wang, Edward P. Ingenito, Charlotte McKee, Yimeng Lu, Julie Lekstrom-Himes, J.S. Elborn - New England Journal of Medicine 2017 cited by 778

  9. Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis

    Authors: James D. Chalmers, Kelly Moffitt, Guillermo Suárez-Cuartín, Oriol Sibila, Simon Finch, Elizabeth Furrie, Alison Dicker, Karolina Wrobel, J.S. Elborn, Brian K. Walker, Lorraine Martin, Sara E. Marshall, Jeffrey Huang, Thomas C. Fardon - American Journal of Respiratory and Critical Care Medicine 2017 cited by 414

  10. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research

    Authors: Adam T. Hill, Charles Haworth, Stefano Aliberti, Alan R. Barker, Francesco Blasi, Wim Boersma, James D. Chalmers, Anthony De Soyza, Katerina Dimakou, J.S. Elborn, Charles Feldman, Patrick A. Flume, Pieter Goeminne, Michael R. Loebinger, Rosario Menéndez, Lucy Morgan, Marlène Murris, Eva Polverino, Alexandra L. Quittner, Felix C. Ringshausen, Gregory Tino, Antoní Torres, Montserrat Vendrell, Tobias Welte, Rob Wilson, Conroy Wong, Anne O’Donnell, Timothy R. Aksamit - European Respiratory Journal 2017 cited by 448

  11. Lung function and microbiota diversity in cystic fibrosis

    Authors: Leah Cuthbertson, Alan W. Walker, Anna Oliver, Geraint B. Rogers, Damian Rivett, Thomas H. Hampton, Alix Ashare, J.S. Elborn, Anthony De Soyza, Mary P. Carroll, Lucas R. Hoffman, Clare Lanyon, Samuel M. Moskowitz, George A. O’Toole, Julian Parkhill, Paul J. Planet, Charlotte C. Tenebäck, Michael M. Tunney, Jonathan B. Zuckerman, Kenneth D. Bruce, Chris Gast - Microbiome 2020 cited by 268

  12. Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease

    Authors: Alison Dicker, Megan Crichton, Eleanor Pumphrey, Andrew Cassidy, Guillermo Suárez-Cuartín, Oriol Sibila, Elizabeth Furrie, Christopher J. Fong, Wasyla Ibrahim, Gill Brady, G.G. Einarsson, J.S. Elborn, Stuart Schembri, Sara E. Marshall, Colin N.A. Palmer, James D. Chalmers - Journal of Allergy and Clinical Immunology 2017 cited by 290

  13. Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis

    Authors: R Chandrasekaran, Micheál Mac Aogáin, James D. Chalmers, J.S. Elborn, Sanjay H. Chotirmall - BMC Pulmonary Medicine 2018 cited by 280

  14. International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety

    Authors: Alexandra L. Quittner, Janice Abbott, Anna M. Georgiopoulos, Lutz Goldbeck, Beth A. Smith, Sarah E. Hempstead, Bruce C. Marshall, Kathryn A. Sabadosa, J.S. Elborn - Thorax 2015 cited by 442

  15. The EMBARC European Bronchiectasis Registry: protocol for an international observational study

    Authors: James D. Chalmers, Stefano Aliberti, Eva Polverino, Montserrat Vendrell, Megan Crichton, Michael R. Loebinger, Katerina Dimakou, I. Clifton, Menno M. van der Eerden, Gernot Rohde, M. Murris‐Espin, Sarah Masefield, Eleanor Gerada, Michal Shteinberg, Felix C. Ringshausen, Charles Haworth, Wim Boersma, Jessica Rademacher, Adam T. Hill, Timothy R. Aksamit, Anne O’Donnell, Lucy Morgan, Branislava Milenković, Leandro Tramma, João Neves, Rosario Menéndez, Perluigi Paggiaro, Victor Botnaru, Sabina Škrgat, Robert C. Wilson, Pieter Goeminne, Anthony De Soyza, Tobias Welte, Antoni Torres, J.S. Elborn, Francesco Blasi - ERJ Open Research 2016 cited by 205

  16. Role of inhaled antibiotics in the era of highly effective CFTR modulators

    Authors: J.S. Elborn, Francesco Blasi, Pierre‐Régis Burgel, D. Peckham - European Respiratory Review 2023 cited by 51

  17. British Thoracic Society Guideline for bronchiectasis in adults

    Authors: Adam T. Hill, A. Sullivan, James D. Chalmers, Anthony De Soyza, J.S. Elborn, R. Andrés Floto, Lizzie Grillo, Kevin Gruffydd‐Jones, Alex Harvey, Charles Haworth, Edwin Hiscocks, John R. Hurst, Christopher Johnson, William P. Kelleher, Pallavi Bedi, Karen Payne, Hashem Saleh, Nicholas Screaton, Maeve P. Smith, Michael M. Tunney, Deborah Whitters, Robert Wilson, Michael R. Loebinger - BMJ Open Respiratory Research 2018 cited by 605

  18. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers

    Authors: G.G. Einarsson, David Comer, L. McIlreavey, Julian Parkhill, Madeleine Ennis, Michael M. Tunney, J.S. Elborn - Thorax 2016 cited by 215

  19. RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis

    Authors: Timothy R. Aksamit, Anthony De Soyza, Tiemo-Joerg Bandel, Margarita Criollo, J.S. Elborn, Elisabeth Operschall, Eva Polverino, Katrin Roth, Kevin Winthrop, Robert C. Wilson - European Respiratory Journal 2018 cited by 186

  20. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice

    Authors: M. Knowles, H. Cuppens, B. Kerem, M. Claustres, J. Dodge, P. Rizzotti, I. Doull, M. Schwarz, J.J. Cassiman, E. Dequeker, T. Casals, M. Macek, C. Bombieri, M. Johannesson, P. Durie, Manfred Stuhrmann, C. Castellani, J.S. Elborn, C. Ferec, J. Zielenski, E. Kerem, B.M. Assael, P.F. Pignatti, P. Farrell, E. Girodon, A. Brown, M. Tzetis, D. Radojkovic, G.R. Cutting, A. Munck, E. Tullis - Journal of Cystic Fibrosis 2008 cited by 591

  21. Lung Microbiota and Bacterial Abundance in Patients with Bronchiectasis when Clinically Stable and during Exacerbation

    Authors: Michael M. Tunney, G.G. Einarsson, Lan Wei, Máire Drain, Erich Klem, Chris R. Cardwell, Madeleine Ennis, Richard C. Boucher, Matthew C. Wolfgang, J.S. Elborn - American Journal of Respiratory and Critical Care Medicine 2013 cited by 328

  22. RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis

    Authors: Anthony De Soyza, Timothy R. Aksamit, Tiemo-Joerg Bandel, Margarita Criollo, J.S. Elborn, Elisabeth Operschall, Eva Polverino, Katrin Roth, Kevin Winthrop, Robert C. Wilson - European Respiratory Journal 2018 cited by 189

  23. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: Formulation, characterisation and functionalisation with dornase alfa (DNase)

    Authors: Jill Deacon, Sharif M. Abdelghany, Derek J. Quinn, Daniela Schmid, Julianne Megaw, Ryan F. Donnelly, David S. Jones, Adrien Kissenpfennig, J.S. Elborn, Brendan Gilmore, Clifford C. Taggart, Christopher J. Scott - Journal of Controlled Release 2014 cited by 149

  24. Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: A systematic review

    Authors: Ranjani Somayaji, Michael D. Parkins, Anand Shah, Stacey L. Martiniano, Michael M. Tunney, Jennifer Kahle, Valerie J. Waters, J.S. Elborn, Scott C. Bell, Patrick A. Flume, Donald R. VanDevanter - Journal of Cystic Fibrosis 2019 cited by 123